UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytogenetic findings in an effusion secondary from pleural mesothelioma

Cancer genetics and cytogenetics, 1987-11, Vol.29 (1), p.75-79

1987

Volltextzugriff (PDF)

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

The New England journal of medicine, 2023-09, Vol.389 (11), p.1009-1022

2023

Volltextzugriff (PDF)

The role of genotype in 104 cases of diffuse large B-cell lymphoma primary of breast

American journal of clinical oncology, 2012-04, Vol.35 (2), p.126-129

2012

Volltextzugriff (PDF)

Aplidin, a Marine Organism-Derived Compound with Potent Antimyeloma Activity In vitro and In vivo

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (13), p.5216-5225

2008

Volltextzugriff (PDF)

Primary Breast Lymphoma: Results of a Controlled Clinical Trial

Oncology, 2005-01, Vol.69 (3), p.256-260

2005

Volltextzugriff (PDF)

Author's reply: Chemotherapy during first trimester of pregnancy

International journal of cancer, 2013-04, Vol.132 (7), p.1729-1729

2013

Volltextzugriff (PDF)

Central nervous system prophylaxis in patients with aggressive diffuse large B cell lymphoma: An analysis of 3,258 patients in a single center

Medical oncology (Northwood, London, England), 2013-06, Vol.30 (2), p.520-6, Article 520

2013

Volltextzugriff (PDF)

ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma

Clinical lymphoma, myeloma and leukemia, 2010-04, Vol.10 (2), p.125-128

2010

Volltextzugriff (PDF)

Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides/Sézary syndrome

Cancer biotherapy & radiopharmaceuticals, 2007-12, Vol.22 (6), p.836-840

2007

Volltextzugriff (PDF)

Rituximab and chemotherapy in primary gastric lymphoma

Cancer biotherapy & radiopharmaceuticals, 2009-02, Vol.24 (1), p.25-28

2009

Volltextzugriff (PDF)

Rituximab and escalated chemotherapy in elderly patients with aggressive diffuse large-cell lymphoma: a controlled clinical trial

Cancer biotherapy & radiopharmaceuticals, 2007-04, Vol.22 (2), p.194-199

2007

Volltextzugriff (PDF)

Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial

Medical oncology (Northwood, London, England), 2005-01, Vol.22 (1), p.57-62

2005

Volltextzugriff (PDF)

Addition of a Short Course of Chemotherapy Did Not Improve Outcome in Patients with Localized Marginal B-Cell Lymphoma of the Orbit

Oncology, 2006-01, Vol.70 (3), p.173-176

2006

Volltextzugriff (PDF)

Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy

Leukemia & lymphoma, 2005-07, Vol.46 (7), p.1023-1028

2005

Volltextzugriff (PDF)

Rituximab and Dose-Dense Chemotherapy in Primary Testicular Lymphoma

Clinical lymphoma & myeloma, 2009-10, Vol.9 (5), p.386-389

2009

Volltextzugriff (PDF)

Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified

Medical oncology (Northwood, London, England), 2008-09, Vol.25 (3), p.360-364

2008

Volltextzugriff (PDF)

Novel therapy in multiple myeloma

Investigational new drugs, 2005-10, Vol.23 (5), p.411-415

2005

Volltextzugriff (PDF)

Adjuvant Radiotherapy in Stage IV Diffuse Large Cell Lymphoma Improve Outcome

Leukemia & lymphoma, 2004, Vol.45 (7), p.1385-1389

2004

Volltextzugriff (PDF)

Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma

Medical oncology (Northwood, London, England), 2006, Vol.23 (2), p.295-300

2006

Volltextzugriff (PDF)

No association between lymphoma and hepatitis C virus

Medical oncology (Northwood, London, England), 2003-01, Vol.20 (2), p.165-168

2003

Volltextzugriff (PDF)

Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy

Medical oncology (Northwood, London, England), 2003-01, Vol.20 (1), p.13-18

2003

Volltextzugriff (PDF)

Adjuvant radiotherapy to sites of previous bulky disease in patients stage iv diffuse large cell lymphoma

International journal of radiation oncology, biology, physics, 1994-11, Vol.30 (4), p.799-803

1994

Volltextzugriff (PDF)

Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma

Medical oncology (Northwood, London, England), 2004, Vol.21 (3), p.269-272

2004

Volltextzugriff (PDF)

Epirubicin (CEOP-Bleo) versus idaurubicin (ClOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkinʼs lymphoma: dose escalation studies

Anti-cancer drugs, 1997-11, Vol.8 (10), p.937-942

1997

Volltextzugriff (PDF)

Late Cardiac Toxicity of Doxorubicin, Epirubicin, and Mitoxantrone Therapy for Hodgkin's Disease in Adults

Leukemia & lymphoma, 1993, Vol.11 (3-4), p.275-279

1993

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Cytogenetic findings in an effusion secondary from pleural mesothelioma

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

The role of genotype in 104 cases of diffuse large B-cell lymphoma primary of breast

Aplidin, a Marine Organism-Derived Compound with Potent Antimyeloma Activity In vitro and In vivo

Primary Breast Lymphoma: Results of a Controlled Clinical Trial

Author's reply: Chemotherapy during first trimester of pregnancy

Central nervous system prophylaxis in patients with aggressive diffuse large B cell lymphoma: An analysis of 3,258 patients in a single center

ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma

Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides/Sézary syndrome

Rituximab and chemotherapy in primary gastric lymphoma

Rituximab and escalated chemotherapy in elderly patients with aggressive diffuse large-cell lymphoma: a controlled clinical trial

Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial

Addition of a Short Course of Chemotherapy Did Not Improve Outcome in Patients with Localized Marginal B-Cell Lymphoma of the Orbit

Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy

Rituximab and Dose-Dense Chemotherapy in Primary Testicular Lymphoma

Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified

Novel therapy in multiple myeloma

Adjuvant Radiotherapy in Stage IV Diffuse Large Cell Lymphoma Improve Outcome

Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma

No association between lymphoma and hepatitis C virus

Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy

Adjuvant radiotherapy to sites of previous bulky disease in patients stage iv diffuse large cell lymphoma

Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma

Epirubicin (CEOP-Bleo) versus idaurubicin (ClOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkinʼs lymphoma: dose escalation studies

Late Cardiac Toxicity of Doxorubicin, Epirubicin, and Mitoxantrone Therapy for Hodgkin's Disease in Adults

Aktive Filter

Suchergebnisse filtern